Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07665073 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Risperidone vs Cariprazine in Acute Mania

Study acronym: RCAM
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Randomized, double-blind, parallel-group study comparing efficacy and safety of Risperidone versus Cariprazine in adults with acute manic episodes. Participants will receive oral study drug for 6 weeks. Primary outcome is change in YMRS total score from baseline to week 6.
Trial Details
NCT Number NCT07665073
Lead Sponsor Pakistan Institute of Medical Sciences
Conditions
(from sponsor)		 Bipolar 1 Disorder
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov